Do analysts prefer MEHA or XBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Xenetic Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend MEHA or BDRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biodexa Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, MEHA or BDRX?

Functional Brands has higher revenue and earnings than Biodexa Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Functional Brands $6.61M 0.29 $760K -$0.32 N/A Biodexa Pharmaceuticals N/A N/A -$8.42M N/A N/A

Is MEHA or BDRX more profitable?

Company Net Margins Return on Equity Return on Assets Functional Brands N/A N/A N/A Biodexa Pharmaceuticals N/A N/A N/A

Do analysts recommend MEHA or APM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aptorum Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, MEHA or APM?

Functional Brands has higher revenue and earnings than Aptorum Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Functional Brands $6.61M 0.29 $760K -$0.32 N/A Aptorum Group N/A N/A -$1.36M N/A N/A

Is MEHA or APM more profitable?

Company Net Margins Return on Equity Return on Assets Functional Brands N/A N/A N/A Aptorum Group N/A N/A N/A

Do analysts rate BCAB or MEHA?

BioAtla currently has a consensus target price of $200.00, indicating a potential upside of 5,630.66%. Given BioAtla's stronger consensus rating and higher probable upside, equities analysts clearly believe BioAtla is more favorable than Functional Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioAtla 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BCAB or MEHA more profitable?

Company Net Margins Return on Equity Return on Assets BioAtla N/A N/A -325.64% Functional Brands N/A N/A N/A

Do analysts recommend APVO or MEHA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptevo Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is APVO or MEHA more profitable?

Functional Brands' return on equity of 0.00% beat Aptevo Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Aptevo Therapeutics N/A -198.50% -117.06% Functional Brands N/A N/A N/A

Functional Brands (MEHA) Competitors

$0.09 +0.02 (+28.26%)

Closing price 06/4/2026 04:00 PM Eastern

Extended Trading

$0.08 -0.01 (-13.70%)

As of 09:05 AM Eastern

Compare

MEHA vs. XBIO, BDRX, APM, BCAB, and APVO

Should you buy Functional Brands stock or one of its competitors? MarketBeat compares Functional Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Functional Brands include Xenetic Biosciences (XBIO), Biodexa Pharmaceuticals (BDRX), Aptorum Group (APM), BioAtla (BCAB), and Aptevo Therapeutics (APVO). These companies are all part of the "pharmaceutical products" industry.

How does Functional Brands compare to Xenetic Biosciences?

Functional Brands (NASDAQ:MEHA) and Xenetic Biosciences (NASDAQ:XBIO) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

15.1% of Xenetic Biosciences shares are held by institutional investors. 4.3% of Functional Brands shares are held by insiders. Comparatively, 7.6% of Xenetic Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Xenetic Biosciences had 1 more articles in the media than Functional Brands. MarketBeat recorded 1 mentions for Xenetic Biosciences and 0 mentions for Functional Brands. Functional Brands' average media sentiment score of 0.87 beat Xenetic Biosciences' score of 0.63 indicating that Functional Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Functional Brands	Positive
Xenetic Biosciences	Positive

Functional Brands has higher revenue and earnings than Xenetic Biosciences. Xenetic Biosciences is trading at a lower price-to-earnings ratio than Functional Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.61M	0.29	$760K	-$0.32	N/A
Xenetic Biosciences	$3.19M	2.46	-$2.68M	-$1.20	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Xenetic Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has a net margin of 0.00% compared to Xenetic Biosciences' net margin of -70.03%. Functional Brands' return on equity of 0.00% beat Xenetic Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Xenetic Biosciences	-70.03%	-39.28%	-33.47%

Summary

Functional Brands beats Xenetic Biosciences on 8 of the 12 factors compared between the two stocks.

How does Functional Brands compare to Biodexa Pharmaceuticals?

Functional Brands (NASDAQ:MEHA) and Biodexa Pharmaceuticals (NASDAQ:BDRX) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Biodexa Pharmaceuticals	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biodexa Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Biodexa Pharmaceuticals' average media sentiment score of 1.89 beat Functional Brands' score of 0.87 indicating that Biodexa Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Functional Brands	Positive
Biodexa Pharmaceuticals	Very Positive

Functional Brands has higher revenue and earnings than Biodexa Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.61M	0.29	$760K	-$0.32	N/A
Biodexa Pharmaceuticals	N/A	N/A	-$8.42M	N/A	N/A

17.5% of Biodexa Pharmaceuticals shares are owned by institutional investors. 4.3% of Functional Brands shares are owned by company insiders. Comparatively, 0.3% of Biodexa Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Functional Brands beats Biodexa Pharmaceuticals on 3 of the 5 factors compared between the two stocks.

How does Functional Brands compare to Aptorum Group?

Functional Brands (NASDAQ:MEHA) and Aptorum Group (NASDAQ:APM) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aptorum Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has higher revenue and earnings than Aptorum Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.61M	0.29	$760K	-$0.32	N/A
Aptorum Group	N/A	N/A	-$1.36M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Aptorum Group	N/A	N/A	N/A

3.8% of Aptorum Group shares are held by institutional investors. 4.3% of Functional Brands shares are held by insiders. Comparatively, 64.0% of Aptorum Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aptorum Group had 1 more articles in the media than Functional Brands. MarketBeat recorded 1 mentions for Aptorum Group and 0 mentions for Functional Brands. Aptorum Group's average media sentiment score of 0.94 beat Functional Brands' score of 0.87 indicating that Aptorum Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Functional Brands	Positive
Aptorum Group	Positive

Summary

Aptorum Group beats Functional Brands on 4 of the 6 factors compared between the two stocks.

How does Functional Brands compare to BioAtla?

BioAtla (NASDAQ:BCAB) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

77.2% of BioAtla shares are owned by institutional investors. 11.8% of BioAtla shares are owned by insiders. Comparatively, 4.3% of Functional Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

BioAtla currently has a consensus target price of $200.00, indicating a potential upside of 5,630.66%. Given BioAtla's stronger consensus rating and higher probable upside, equities analysts clearly believe BioAtla is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioAtla	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has higher revenue and earnings than BioAtla. Functional Brands is trading at a lower price-to-earnings ratio than BioAtla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioAtla	$2M	2.90	-$59.61M	-$41.72	N/A
Functional Brands	$6.61M	0.29	$760K	-$0.32	N/A

Company	Net Margins	Return on Equity	Return on Assets
BioAtla	N/A	N/A	-325.64%
Functional Brands	N/A	N/A	N/A

In the previous week, BioAtla's average media sentiment score of 0.93 beat Functional Brands' score of 0.87 indicating that BioAtla is being referred to more favorably in the media.

Company	Overall Sentiment
BioAtla	Positive
Functional Brands	Positive

Summary

BioAtla beats Functional Brands on 8 of the 12 factors compared between the two stocks.

How does Functional Brands compare to Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ:APVO) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

In the previous week, Functional Brands' average media sentiment score of 0.87 beat Aptevo Therapeutics' score of 0.62 indicating that Functional Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Aptevo Therapeutics	Positive
Functional Brands	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aptevo Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has higher revenue and earnings than Aptevo Therapeutics. Functional Brands is trading at a lower price-to-earnings ratio than Aptevo Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aptevo Therapeutics	N/A	N/A	-$25.97M	-$197.60	N/A
Functional Brands	$6.61M	0.29	$760K	-$0.32	N/A

8.1% of Aptevo Therapeutics shares are owned by institutional investors. 0.1% of Aptevo Therapeutics shares are owned by company insiders. Comparatively, 4.3% of Functional Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Functional Brands' return on equity of 0.00% beat Aptevo Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aptevo Therapeutics	N/A	-198.50%	-117.06%
Functional Brands	N/A	N/A	N/A

Summary

Functional Brands beats Aptevo Therapeutics on 7 of the 11 factors compared between the two stocks.

Get Functional Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEHA vs. The Competition

Export

Metric	Functional Brands	Medicinal Chemicals Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$1.50M	$5.48B	$4.33B	$12.38B
Dividend Yield	N/A	N/A	7.93%	5.31%
P/E Ratio	-0.27	N/A	21.76	24.35
Price / Sales	0.29	0.29	231.96	95.26
Price / Cash	0.96	0.96	53.68	55.53
Price / Book	0.97	1,108.49	30.95	6.72
Net Income	$760K	-$1.41M	$109.80M	$337.03M
7 Day Performance	N/A	-7.28%	-0.46%	-0.16%
1 Month Performance	N/A	-18.74%	4.53%	3.74%
1 Year Performance	N/A	N/A	15.48%	34.34%

Functional Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEHA Functional Brands	1.0601 of 5 stars	$0.09 +28.3%	N/A	N/A	$1.50M	$6.61M	N/A	33	Positive News Short Interest Decrease Gap Down
XBIO Xenetic Biosciences	0.6632 of 5 stars	$3.15 +2.2%	N/A	+8.2%	$7.06M	$3.19M	N/A	4	News Coverage Positive News
BDRX Biodexa Pharmaceuticals	0.7665 of 5 stars	$3.47 +3.3%	N/A	-94.1%	$6.93M	N/A	N/A	20	Positive News Analyst Downgrade
APM Aptorum Group	1.208 of 5 stars	$1.03 +22.9%	N/A	-8.4%	$6.54M	N/A	N/A	30	Gap Down High Trading Volume
BCAB BioAtla	1.6299 of 5 stars	$3.93 -3.0%	$200.00 +4,989.1%	-85.3%	$6.51M	$2M	N/A	60	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEHA) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Functional Brands (MEHA) Competitors

MEHA vs. XBIO, BDRX, APM, BCAB, and APVO

How does Functional Brands compare to Xenetic Biosciences?

Summary

How does Functional Brands compare to Biodexa Pharmaceuticals?

Summary

How does Functional Brands compare to Aptorum Group?

Summary

How does Functional Brands compare to BioAtla?

Summary

How does Functional Brands compare to Aptevo Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Functional Brands (MEHA) Competitors

MEHA vs. XBIO, BDRX, APM, BCAB, and APVO

How does Functional Brands compare to Xenetic Biosciences?

Do insiders & institutionals believe in MEHA or XBIO?

Does the media prefer MEHA or XBIO?

Which has better earnings & valuation, MEHA or XBIO?

Do analysts prefer MEHA or XBIO?

Is MEHA or XBIO more profitable?

Summary

How does Functional Brands compare to Biodexa Pharmaceuticals?

Is MEHA or BDRX more profitable?

Do analysts recommend MEHA or BDRX?

Does the media refer more to MEHA or BDRX?

Which has better valuation & earnings, MEHA or BDRX?

Do institutionals & insiders have more ownership in MEHA or BDRX?

Summary

How does Functional Brands compare to Aptorum Group?

Do analysts recommend MEHA or APM?

Which has stronger valuation & earnings, MEHA or APM?

Is MEHA or APM more profitable?

Do institutionals and insiders believe in MEHA or APM?

Does the media favor MEHA or APM?

Summary

How does Functional Brands compare to BioAtla?

Do institutionals & insiders believe in BCAB or MEHA?

Do analysts rate BCAB or MEHA?

Which has stronger earnings & valuation, BCAB or MEHA?

Is BCAB or MEHA more profitable?

Does the media prefer BCAB or MEHA?

Summary

How does Functional Brands compare to Aptevo Therapeutics?

Does the media favor APVO or MEHA?

Do analysts recommend APVO or MEHA?

Which has stronger valuation and earnings, APVO or MEHA?

Do insiders and institutionals have more ownership in APVO or MEHA?

Is APVO or MEHA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools